Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows

v3.10.0.1
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash Flows from Operating Activities:    
Net loss $ (11,374) $ (8,747)
Research and development-licenses acquired, expensed 75 2,075
Issuance of common shares - Founders Agreement 0 1,232
Stock-based compensation expenses 2,966 397
Depreciation expense 122 0
Changes in operating assets and liabilities:    
Prepaid expenses and other assets (957) (8)
Interest receivables (303) 0
Accounts payable and accrued expenses 155 2,295
Payables and accrued expenses - related party 50 13
Accrued interest - related party 0 (413)
Deferred rent 345 0
Notes payable - related party 0 146
Net cash used in operating activities (8,921) (3,010)
Cash Flows from Investing Activities:    
Purchase of short-term investment (certificates of deposit) (35,000) (20,038)
Maturity of certificate of deposit 26,002 0
Purchase of research and development licenses (75) (575)
Purchase of fixed assets (5,418) 0
Net cash used in investing activities (14,491) (20,613)
Cash Flows from Financing Activities:    
Payment of Fortress Note 0 (320)
Proceeds from issuance of common stock and warrants, net of offering cost of $5,671 0 50,234
Proceeds from exercise of warrants 181 0
Net cash provided by financing activities 181 49,914
Net change in cash, cash equivalents and restricted cash (23,231) 26,291
Cash, cash equivalents and restricted cash, beginning of the period 35,475 27,499
Cash, cash equivalents and restricted cash, end of the period 12,244 53,790
Supplemental disclosure of cash flow information:    
Cash paid for interest 0 413
Supplemental disclosure of noncash investing and financing activities:    
Fixed assets (acquired but not paid) 818 0
Issuance of common shares - Founders Agreement 9,558 4,396
Common shares issuable for license acquired $ 0 $ 1,682